BROW MEDICAL CENTRE
THE BROW, BURGESS HILL
CKD 5
The percentage of patients on the CKD register with hypertension and proteinuria who are treated with an angiotensin coverting enzyme inhibitor (ACE-I) or angiotensin receptor blocker (AEB) (unless a contraindication or side effects are recorded)
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| CKD 4 | 2007 | 87 | 103 | 84.5% | |
| CKD 4 | 2008 | 114 | 133 | 85.7% | |
| CKD 5 | 2009 | 11 | 11 | 100.0% | |
| CKD 5 | 2010 | 17 | 17 | 100.0% | |
| CKD 5 | 2011 | 15 | 17 | 88.2% | |
| CKD 5 | 2012 | 16 | 19 | 84.2% | |
| CKD 5 | 2013 | 17 | 18 | 94.4% | |
| CKD003 | 2014 | 18 | 19 | 94.7% | |
| CKD003 | 2015 | 16 | 18 | 88.9% | |
| NM84 | 2018 | 14 | 18 | 77.8% | |
| NM84 | 2019 | 13 | 16 | 81.2% | |
| NM84 | 2020 | 14 | 19 | 73.7% | |
| NM84 | 2022 | 16 | 24 | 66.7% | |
| NM84 | 2023 | 18 | 27 | 66.7% |
